BMO Capital Maintains Their Buy Rating on HCP Inc (HCP)


BMO Capital analyst John Kim maintained a Buy rating on HCP Inc (HCP) yesterday and set a price target of $33. The company’s shares closed yesterday at $30.75, close to its 52-week high of $31.65.

According to TipRanks.com, Kim is a 4-star analyst with an average return of 4.7% and a 59.5% success rate. Kim covers the Financial sector, focusing on stocks such as Apartment Investment & Management, Franklin Street Properties, and National Health Investors.

Currently, the analyst consensus on HCP Inc is a Strong Buy with an average price target of $31.

See today’s analyst top recommended stocks >>

HCP Inc’s market cap is currently $14.45B and has a P/E ratio of 86.45. The company has a Price to Book ratio of 2.85.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

HCP, Inc. is a real estate investment trust which invests primarily in real estate serving the healthcare industry in the United States. It acquires, develops, leases, sells, and manages healthcare real estate and provides mortgage and other financing to healthcare providers.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts